Discontinued — last reported Q2 '21
Business Segments · Amortization
Covance — Amortization
Analysis
StatementSegment
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2021
Last reportedQ2 2021Aug 5, 2021
Rolls up toAdjustment for Amortization
How to read this metric
An increase in amortization expense typically reflects recent M&A activity or the acquisition of significant intellectual property, while a decrease suggests that older acquired assets are becoming fully amortized. High levels of amortization relative to segment revenue may mask the underlying operational cash flow generation of the business unit.
Detailed definition
This metric represents the non-cash expense recognized over the useful life of intangible assets acquired through busine...
Peer comparison
Comparable to 'Amortization of Acquired Intangibles' reported by other large contract research organizations (CROs) or life sciences services firms that utilize an acquisition-heavy growth strategy.
Metric ID:
lh_segment_covance_amortizationHistorical Data
1 periods
| Q2 '21 | |
|---|---|
| Value | $28.00M |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Labcorp Holdings's covance — amortization?
- Labcorp Holdings (LH) reported covance — amortization of $28.00M in Q2 2021.
- What does covance — amortization mean?
- The annual non-cash expense related to the gradual write-down of intangible assets acquired during the purchase of businesses within the drug development segment.